Literature DB >> 4140084

Alpha-fetoprotein in primary liver cancer and other diseases.

M Kew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4140084      PMCID： PMC1412983          DOI： 10.1136/gut.15.10.814

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  70 in total

1.  Association of embryonic antigens with experimentally induced hepatic lesions in the rat.

Authors:  M Stanislawski-Birencwajg; J Uriel; P Grabar
Journal:  Cancer Res       Date:  1967-11       Impact factor: 12.701

2.  Occurrence of fetoprotein in patients with neoplasms and non-neoplastic diseases.

Authors:  J Masopust; K Kithier; J Rádl; J Koutecký; L Kotál
Journal:  Int J Cancer       Date:  1968-05-15       Impact factor: 7.396

3.  Alpha-1 fetoglobulin in the diagnosis of human hepatoma.

Authors:  M E Alpert; J Uriel; B de Nechaud
Journal:  N Engl J Med       Date:  1968-05-02       Impact factor: 91.245

4.  Foetoglobin and primary liver cancer.

Authors:  J B Smith; D Todd
Journal:  Lancet       Date:  1968-10-12       Impact factor: 79.321

5.  Embryonal serum alpha-globulin in cancer patients: diagnostic value.

Authors:  G I Abelev; I V Assecritova; N A Kraevsky; S D Perova; N I Perevodchikova
Journal:  Int J Cancer       Date:  1967-09-15       Impact factor: 7.396

6.  Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data.

Authors:  G I Abelev
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

7.  [Value of the study of serum alpha-1-feto-protein in diagnosis of primary cancer of the liver].

Authors:  R Masseyeff; M Sankalé; M Onde; A Menye; R Camain; C Quénum; L Maydat; P Mattern; J P Ancelle; L Leblanc
Journal:  Bull Soc Med Afr Noire Lang Fr       Date:  1968

8.  [Diagnosis of primary cancer of the liver by immunological methods].

Authors:  J Uriel; B de Nechaud; M Stanislawski-Birencwajg; R Masseyeff; L Leblanc; F Loisillier; C Quenum; P Grabar
Journal:  Presse Med       Date:  1968-06-29       Impact factor: 1.228

9.  Serum alpha-feto-protein. I. Immunodiffusion and immuno-assay results in cases of primary cancer of the liver.

Authors:  L R Purves; M Macnab; I Bersohn
Journal:  S Afr Med J       Date:  1968-11-02

10.  Serum alpha-1 foeto-protein (fetuin) in children with malignant ovarian or testicular teratomas. Preliminary results.

Authors:  C Mawas; M Kohen; J Lemerle; D Buffe; O Schweisguth; P Burtin
Journal:  Int J Cancer       Date:  1969-01-15       Impact factor: 7.396
View more
  17 in total

Review 1.  Geographic heterogeneity of hepatocellular carcinoma.

Authors:  K Okuda
Journal:  Gastroenterol Jpn       Date:  1990-12

Review 2.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Reappraisal of surgical treatment of small hepatocellular carcinomas in cirrhosis: clinicopathological study of resection or transplantation.

Authors:  L Belli; F Romani; L S Belli; L De Carlis; G Rondinara; F Baticci; E Del Favero; E Minola; F Donato; V Mazzaferro
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

4.  Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.

Authors:  Xin-Sen Xu; Kai Qu; Chang Liu; Yue-Lang Zhang; Jun Liu; Yan-Zhou Song; Peng Zhang; Si-Nan Liu; Hu-Lin Chang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

5.  Circulating intercellular adhesion molecule 1 predicts non-specific elevation of alpha 1-fetoprotein.

Authors:  E Falleti; C Fabris; M Pirisi; G Soardo; D Vitulli; P Toniutto; E Bartoli; N Bortolotti; F Gonano
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion.

Authors:  I M Murray-Lyon; A H Orr; B Gazzard; J Kohn; R Williams
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

7.  Serum and tumour ferritins in primary liver cancer.

Authors:  M C Kew; J D Torrance; D Derman; M Simon; G M Macnab; R W Charlton; T H Bothwell
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

8.  Alpha1-fetoprotein in the diagnosis of hepatoma: statistical and cost benefit aspects.

Authors:  P J Phillips; R Rowland; D P Reid; M E Coles
Journal:  J Clin Pathol       Date:  1977-12       Impact factor: 3.411

9.  Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.

Authors:  N Eleftheriou; J Heathcote; H C Thomas; S Sherlock
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

10.  Clinical outcomes of patients with a high alpha-fetoprotein level but without evident recurrence on CT or MRI in surveillance after curative-intent treatment for hepatocellular carcinoma.

Authors:  Jihyuk Lee; Ijin Joo; Dong Ho Lee; Sun Kyung Jeon; Jeong Min Lee
Journal:  Abdom Radiol (NY)       Date:  2020-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.